Brain volume loss in individuals over time: Source of variance and limits of detectability
Background: Brain volume loss measured from magnetic resonance imaging (MRI) is a marker of neurodegeneration and predictor of disability progression in MS, and is commonly used to assess drug efficacy at the group level in clinical trials. Whether measures of brain volume loss could be useful to he...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | NeuroImage |
Online Access: | http://www.sciencedirect.com/science/article/pii/S105381192030224X |